Drug Topics - June 16, 2008 - (Page 18)

18 DRUG TOPICS JUNE 16, 2008 www.drugtopics.com > > >Latebreakers… In Reid Paul hile many outsiders were surprised when John Gans, Pharm.D., announced that he would be leaving the American Pharmacists Association at its annual conference in San Diego, plans were already well underway to ensure that the transformation would be orderly. In fact, APhA retained the Miles Lehane Companies, an executive leadership consulting firm more than three years ago to help smooth out the process. “It has been close to 20 years since the organization has needed to hire a new John Gans will step CEO,” explained David Miles, chairdown as head of APhA next year. man of Miles Lehane. “APhA recognized that there were a lot of important variables involved and that finding a chief executive has changed dramatically in that time.” “I am proud of my years of service to patients and the pharmacy profession,” Gans told attendees at the conference in March. “Leading APhA for almost 20 years has been a sincere privilege and honor. Also, I am very proud that APhA continues to identify, create, and support opportunities for pharmacists to make a difference in the lives of patients.” Depth APhA begins search for new head W Selection criteria Perhaps one of the biggest challenges for APhA was determining the criteria for its next CEO. Below are some of the criteria APhA is using as it narrows its search: • Must be a pharmacist as required by the APhA bylaws • Must be an APhA member • Must be a U.S. citizen • Must have demonstrated prior or current leadership responsibilities • Must be able to pass a government background check. pharmacist. That caused some controversy, Miles admitted, and disqualified a number of candidates. Many pharmacy leaders strongly believe that APhA should be led by a pharmacist. “I do think it has to be a pharmacist; there are really good people in pharmacy executive jobs around the industry,” commented Lucinda Maine, Ph.D., R.Ph., executive VP of the American Association of Colleges of Pharmacy. Maine was part of the team at APhA that helped hire Gans back in 1989. Prior to joining APhA, Gans was Dean of the School of Pharmacy at the Philadelphia College of Pharmacy & Science. Like many, Maine believes that the next APhA leader may come out of the for-profit side of the profession. “We need a fabulous practitioner leader,” she explained. “APhA CEOs for a long time have come out of academia. That’s great, but in the coming years, we need someone who has done it all and can run a highly complex $30 million organization.” Maine would not comment on whether she was interested in the position herself. Speculation has also circled around Susan Winckler, another former APhA staffer who is currently chief of staff at the Food & Drug Administration. Winckler, who declined to comment on the position, was on the staff at APhA before she joined FDA. The timeline for change At the convention Gans insisted that now was the best time for a change. “I believe that 2009 is the right time for a leadership transition for a number of reasons,” he told attendees. “The association is operationally sound, has a superb staff, and is well positioned for continued success.” So far the effort seems to be on track. APhA has already received many applications through a special Web site the organization set up for the search: www.aphaceosearch.com. Miles expects the list to be pared down to 10 candidates by September or October with the final three candidates selected before the end of the year. “As we embark upon our search for a new leader for APhA, we look forward to building on Dr. Gans’ legacy, and to leading APhA and the profession to even higher levels of achievement,” said Timothy Tucker, president of APhA. Building consensus According to Miles, APhA began the process by assembling a committee to establish the key criteria for selecting a new CEO. “APhA spent a lot of time trying to build consensus on the criteria,” he said. While there was agreement that the new head for the organization must have a background exhibiting leadership, there was less agreement on whether it was necessary to require the candidate be a licensed Photo: Judy Chi http://www.drugtopics.com http://www.aphaceosearch.com

Table of Contents Feed for the Digital Edition of Drug Topics - June 16, 2008

Drug Topics - June 16, 2008 Contents Latebreakers Letters Latebreakers in Depth Pharmacists Lose in Final ESRD Rule New Drug Helps Palliative Patients on Opioids Take Care of Business Oral Treatment Reduces Multiple Sclerosis Flare-ups Beware of Inflammatory Masses From Implantable Infusion Systems Safer Therapeutic Options Emerging for Atrial Fibrillation Congressional Committee Chair Calls for Action Against Hospital Infections This Software System Helps Hospitals Manage Anticoagulation Therapy Rx Care Community Practice JP at Large Self-Care Cover Story Long-Term Care Chains and Business Technology Technology Update Continuing Education New Products Advertisers Index Classified Viewpoint

Drug Topics - June 16, 2008

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.